fda glp-1 compounding enforcement september 2025 Beyond the Headlines: Warning Letters to Compounders FDA Crackdown Puts Pressure on
Description
In a prospective study of T2DM patients, six months of liraglutide therapy improved diastolic function and reduced left ventricular mass index [44], while additional echocardiographic studies have reported improvements in global longitudinal strain and left ventricular mass with GLP-1 receptor agonists [45]

Track your weight daily but evaluate weekly averages to distinguish true plateaus from normal fluctuation

We had the question, Would that translate in potentially impacting their cancer risks? George adds that the study had several limitations and that the data showed that older adults on GLP-1s experienced fewer benefits against cancer than middle-aged and younger patients
You might say, I love the idea of weekly shots or Daily works better for me, and your provider can take that into consideration

Everyones talking about them for weight loss and diabetes

Hammoud R et al
